GB2068225A — Dermatological compositions containing hydrogen peroxide
Assigned to QUINODERN Ltd · Expires 1981-08-12 · 45y expired
What this patent protects
A dermatological composition, for treating skin conditions such as acne contains hydrogen peroxide buffered to a pH of less than 7 in the form of a non-greasy single phase aqueous gel. The buffer may be selected from lactic acid, citric acid, tartaric acid, maleic acid, hydroxysu…
USPTO Abstract
A dermatological composition, for treating skin conditions such as acne contains hydrogen peroxide buffered to a pH of less than 7 in the form of a non-greasy single phase aqueous gel. The buffer may be selected from lactic acid, citric acid, tartaric acid, maleic acid, hydroxysuccinic acid, potassium acid phosphate, sodium and potassium acid citrate and sodium and potassium acid tartrate.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.